cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) and Inflammation

cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) has been researched along with Inflammation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brozoski, D; Traub, RJ	1

Other Studies

1 other study(ies) available for cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) and Inflammation

Article	Year
Anti-somatostatin antisera, but neither a somatostatin agonist (octreotide) nor antagonist (CYCAM), attenuates hyperalgesia in the rat. Peptides, 1996, Volume: 17, Issue:5 Topics: Animals; Antibodies, Blocking; Antibodies, Monoclonal; Antineoplastic Agents, Hormonal; Dose-Response Relationship, Drug; Hormone Antagonists; Hormones; Hyperalgesia; Inflammation; Male; Octreotide; Rats; Rats, Sprague-Dawley; Somatostatin	1996

Article

Year

Anti-somatostatin antisera, but neither a somatostatin agonist (octreotide) nor antagonist (CYCAM), attenuates hyperalgesia in the rat.

Peptides, 1996, Volume: 17, Issue:5

Topics: Animals; Antibodies, Blocking; Antibodies, Monoclonal; Antineoplastic Agents, Hormonal; Dose-Response Relationship, Drug; Hormone Antagonists; Hormones; Hyperalgesia; Inflammation; Male; Octreotide; Rats; Rats, Sprague-Dawley; Somatostatin

1996